NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's potential impact on NGENF's stock value.

A RARE AND FATAL DEGENERATIVE DISEASE THAT CAUSES PROGRESSIVE DAMAGE TO NERVE CELLS AND LOSS OF WHITE MATTER IN THE BRAIN. GETTING THAT DIAGNOSIS WHEN FAMILIES WOULD GET THAT, THE DOCTORS WOULD GIVE ...

Thanks to new high-frequency electrical stimulation that blocks spasticity, two paralyzed patients suffering from muscle stiffness after spinal cord injury benefit from rehabilitation protocols for ...